Investigating the Cardiotoxic Behavior of Doxorubicin on the ECM Through CCN2 Expression in
Cardiac Fibroblasts
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BACKGROUND
The American Cancer Society® estimates over 1.9 million people
in the US will be diagnosed with cancer, and roughly 600,000
people will lose their battle to cancer in 2022. Consequently,
patients who undergo cancer treatment will present with an array
of adverse drug reactions. One adverse effect, cardiotoxicity,
negatively impacts cardiac function as a result of myocardial
damage or ventricular function.1 Doxorubicin (DOX) is an
anthracycline chemotherapeutic that is commonly used and has
shown to have a dose-dependent adverse effect on the heart
through a variety of proposed mechanisms.2 The extracellular
matrix (ECM), an essential component of the heart, is a key
regulator in cardiac remodeling, provides structural integrity, and
helps maintain homeostasis of the heart.3 Components that make
up the ECM are produced in part from the expression of Cellular
Communication Network Factor 2 (CCN2).4 We investigated
doxorubicin adverse effects on the cardiac extracellular matrix by
means of disruption of ECM depositor, CCN2, in NIH3T3 mouse
embryonic fibroblast and primary cardiac fibroblast.
METHODS
Cell Culture: NIH3T3 and mouse primary cardiac fibroblast cell
lines were cultured. Brought to confluency prior to seeding
experimental dishes using proper media and vitamin C spiked
media during treatments. All treatments lasted 24 hours.
Cytotoxicity: NIH3T3 cells were seeded onto a 96-well plate and
treated with an array of DOX concentrations. Using alamarBlue™
resazurin dye with microplate reader reading fluorescence at
560/590nm wavelength to achieve cell viability.
Protein Isolation: NIH3T3 and mouse primary cardiac fibroblast
were lysed with RIPA buffer containing protease inhibitors and
EDTA. Cell lysates were then sonicated and centrifuged at 14Gs
at 4°C for 15 minutes. Supernatants collected and BCA assay
performed to determine sample protein concentration.
Western Blot: Total protein cell lysate samples were loaded in 412% gradient SDS-PAGE, ran for 45 minutes, then transferred
onto PVDF membranes. Membranes were immunoblotted with
primary antibodies for CCN2 and related proteins along with
house keeping protein, β-actin. Membranes were imaged on
LiCor Odyssey CLx imager after secondary antibody incubation
and wash steps. Densitometry analysis was used after imaging.
RNA Isolation: RNA was isolated from NIH3T3 cells using
Qiagen RNeasy kit.
RT-qPCR: RNA was as transformed into cDNA using SYBR
Green qPCR master mix. cDNA was loaded on precoated 96-well
plate from Qiagen, RT2 Profiler Array TGF-BMP signaling
pathway plate.

RESULTS

RESULTS (CONT.)

Figure 1. NIH3T3 alamarBlue™ cytotoxicity assay with
increasing DOX concentrations. Cell viability is shown to
decrease with increasing concentrations of DOX. (n=8)
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Figure 2. Effects of DOX treatments on CCN2 and related proteins. Western blot and
densitometry analysis (A-D). β-actin utilized as housekeeping protein. TGF-β1 was used as a
positive control. (A) NIH3T3 cells treated with varying doses of DOX for 24 hours. Densitometry
reveals CCN2 decrease with increasing DOX concentrations. (B) Mouse primary cardiac
fibroblast undergoing same treatments from (A). Similar trend in decrease in CCN2 expression
as NIH3T3 cells. (C) NIH3T3 cells treated with and without DOX as well as TGF-β1 for 24 hours.
Densitometry indicates decrease in BMP1 expression in the presence of DOX but requires
statistical analysis to determine significance. (D) NIH3T3 cells undergoing same treatment as
described in (C) probing for SMAD2. Densitometry reveals that DOX reduced SMAD2
expression.

Figure 3. RT2 Profiler Array TGF-BMP signaling pathway PCR
plate use for NIH3T3 cells treated with and without DOX and
TGF-β1. Ten genes showed upregulation in the presence od DOX
while only one gene was downregulated.
Table 1. Genes, p-values,
and log fold changes for
upregulated
and
downregulated genes from
RT2 Profiler Array. Of the 89
total genes, eleven genes
were displayed for their
significance (p<0.05).

CONCLUSION
DOX is a commonly used chemotherapeutic that has a potent effect on the heart. To better
understand how potent DOX was to fibroblast, we conducted a cytotoxicity assay. In a
cytotoxicity assay of NIH3T3 cells, we observed a maximum DOX concentration of 50 µM lead
to >40% viability, allowed for maximum concentrations of 2.5 µM to be used in subsequent
experiments. Western blots analyzing CCN2 for both NIH3T3 and primary cardiac cells indicated
that CCN2 expression showed a similar trends when DOX concentrations increased. BMP1 and
SMAD2 are inducers of CCN2 that appear to decrease in expression with DOX. Finally, RTqPCR data from NIH3T3 cells on TGF-BMP signaling pathway shows a handful of genes that
were upregulated and one gene that was downregulated. Future work would entail probing
collagen and fibronectin proteins in western blots under same conditions to analyze ECM protein
disruption from DOX.
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